These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10673687)

  • 1. Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases.
    Schulenburg A; Kalhs P; Worel N; Höcker P; Knöbl P; Greinix HT
    Bone Marrow Transplant; 2000 Jan; 25(2):223-4. PubMed ID: 10673687
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics and immunophenotypic characterization of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Albo C; de la Fuente J; Ares C; Alonso C; Feteira E
    Haematologica; 2004 Jul; 89(7):845-51. PubMed ID: 15257937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
    Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
    Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
    Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
    Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
    Kanz L; Brugger W; Mertelsmann R
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):10-8. PubMed ID: 7528446
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
    Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
    Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
    Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
    Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation.
    Ito C; Sato H; Ando K; Watanabe S; Yoshiba F; Kishi K; Furuya A; Shitara K; Sugimoto S; Kohno H; Hiraoka A; Hotta T
    Bone Marrow Transplant; 2003 Aug; 32(4):391-8. PubMed ID: 12900775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
    Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low cell concentration of cryopreserved autologous CD34+ peripheral blood progenitor cells does not impair hematopoietic recovery after transplantation.
    Caravita T; Bruno A; Adorno G; Santinelli S; Siniscalchi A; Abruzzese E; Palombi F; Tamburini A; Ballatore G; Cudillo L; Amadori S; Del Proposto G; Isacchi G
    Transfus Apher Sci; 2003 Oct; 29(2):189-92. PubMed ID: 12941360
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
    Hosing C; Qazilbash MH; Kebriaei P; Giralt S; Davis MS; Popat U; Anderlini P; Shpall EJ; McMannis J; Körbling M; Champlin RE
    Br J Haematol; 2006 Jun; 133(5):533-7. PubMed ID: 16681642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
    Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
    Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
    Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
    J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience.
    Arat M; Arslan O; Ayyildiz E; Topcuoglu P; Dalva K; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):189-91. PubMed ID: 15172622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemispheric stroke does not mobilize cd34+ hematopoietic stem cells into the peripheral blood.
    Höchsmann B; Huber R; Schauwecker P; Schrezenmeier H; Wiesneth M; Storch A
    Neurology; 2009 Apr; 72(14):1277-8. PubMed ID: 19349609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.